2m 2m 2m 2m 2m 2m 2m
ELICIO THERAPTCS (ELTX)
NASDAQ
$3.26-$0.04 (-1.06%)
Price as of Jul 14, 2026 10:13 AM EDT- $86.4MMarket Cap
- -63.44%1-Year Change
- BiotechnologyIndustry
ELICIO THERAPTCS (ELTX)
$3.26-$0.04 (-1.06%)
ELTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.29 | ||
Change | -$0.19 (-5.46%) | ||
Open | $3.40 | ||
High | $3.48 | ||
Low | $3.13 | ||
Previous Close | $3.48 | ||
Volume | 493,446 | ||
30-Day Average Volume | 5,006,457 | ||
1-Week Change | -0.15% | ||
1-Month Change | -77.85% | ||
1-Year Change | -63.44% | ||
3-Year Change | -70.23% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.3M | ||
Total Assets | $22.7M | ||
Market Cap | $86.4M | ||
Enterprise Value | $80.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.8M | ||
Free Cash Flow | -$11.6M | ||
EBIT | -$11.8M | ||
EBITDA | -$11.8M | ||
Net Working Capital | $9.0M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -60 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue